Trepo - Selaus tekijän mukaan "Wilson, Eleanor"

Viitteet 1-2 / 2

    • Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults 

      Wilson, Eleanor; Goswami, Jaya; Baqui, Abdullah H; Doreski, Pablo A; Perez-Marc, Gonzalo; Zaman, Khalequ; Monroy, Jorge; Duncan, Christopher J A; Ujiie, Mugen; Rämet, Mika; Pérez-Breva, Lina; Falsey, Ann R; Walsh, Edward E; Dhar, Rakesh; Wilson, Lauren; Du, Jiejun; Ghaswalla, Parinaz; Kapoor, Archana; Lan, Lan; Mehta, Shraddha; Mithani, Runa; Panozzo, Catherine A; Simorellis, Alana K; Kuter, Barbara J; Schödel, Florian; Huang, Wenmei; Reuter, Caroline; Slobod, Karen; Stoszek, Sonia K; Shaw, Christine A; Miller, Jacqueline M; Das, Rituparna; Chen, Grace L (13.12.2023)
      article
      BACKGROUND: Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under clinical ...

    • Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults 

      Goswami, Jaya; Baqui, Abdullah H.; Doreski, Pablo A.; Marc, Gonzalo Perez; Jimenez, Gilberto; Ahmed, Salahuddin; Zaman, Khalequz; Duncan, Christopher J.A.; Ujiie, Mugen; Rämet, Mika; Pérez-Breva, Lina; Lan, Lan; Du, Jiejun; Kapoor, Archana; Mehta, Shraddah; Tomassini, Joanne E.; Huang, Wenmei; Zhou, Honghong; Stoszek, Sonia K.; Priddy, Frances; Lin, Nina; Cam, Nancy Le; Shaw, Christine A.; Slobod, Karen; Wilson, Eleanor; Miller, Jacqueline M.; Das, Rituparna (2024)
      article
      Background: The mRNA-1345 vaccine demonstrated efficacy against respiratory syncytial virus (RSV) disease with acceptable safety in adults aged ≥60 years in the ConquerRSV trial. Here, humoral immunogenicity results from ...